Clinical Trial Update: Spermatogonial Differentiation Via Testicular Organoid [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial by CellARTs Inc. is evaluating spermatogonial differentiation using a testicular organoid to treat male infertility due to gene abnor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Male Infertility
• Male Sterility

Drugs mentioned

• Spermatogonial Differentiation Via Testicular Organoid

Snippet

Sponsor: CellARTs Inc. | Conditions: Infertility, Male, Gene Abnormality | Phase 1, Phase 2 | Status: RECRUITING